= 1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene, R f8 = (CF 2 ) 7 CF 3 ]w as prepared from the fluorous pyridine 3,5-NC 5 H 3 (CH 2 CH 2 R f8 ) 2 (2.1 equiv.) and the pyridine complex(H 2 IMes)(NC 5 H 5 ) 2 (Cl) 2 Ru(= CHPh). 3,5-NC 5 H 3 (CH 2 CH 2 R f8 ) 2 was synthesized by aH eck reaction of 3,5-dibromopyridine and the fluorousa lkene H 2 C=CHR f8 [2.4 equiv. ;P d(OAc) 2 (cat.), n-Bu 4 N + Br À /NaOAc( 2.0 equiv.)],f ollowed by hydrogenation. The catalyst shows dramatic rate accelerations in the ring-closing metatheses of a,w-dienes under fluorous/organic liquid/ liquid biphasic conditions [e.g.,p erfluoro(methyldecalin)/ CD 2 Cl 2 ]r elative to rates under monophasic organic conditions (e.g.,C D 2 Cl 2 ). These catalysts require initial dissociation of the pyridine ligands to generate the active species, which can either combine with an alkene (productive) or recombine with ap yridine (unproductive). In the case of (H 2 IMes)[3,5-NC 5 H 2 (CH 2 CH 2 R f8 ) 2 ] 2 (Cl) 2 Ru(= CHPh), fluorophilic 3,5-NC 5 H 3 (CH 2 CH 2 R f8 ) 2 transfers to the fluorousp hase, in accord with its CF 3 C 6 F 11 /toluene partition coefficient [93.9:6.1 vs. 39.8:60.2 for (H 2 IMes)[3,5-NC 5 H 3 (CH 2 CH 2 R f8 ) 2 ] 2 (Cl) 2 Ru(= CHPh)], which decreases the fraction of unproductive events.Scheme1.Phase-transfer activationo fcatalysts:general principles and phosphine-containing metathesis catalystss tudied previously.Cy= cyclohexyl, Mes = 2,4,6-trimethylphenyl.[a] Dr.